2025
Comparison of prognostic accuracy of HCC staging systems in patients undergoing TACE
Kasolowsky V, Gross M, Madoff D, Duncan J, Taddei T, Strazzabosco M, Jaffe A, Chapiro J. Comparison of prognostic accuracy of HCC staging systems in patients undergoing TACE. Clinical Imaging 2025, 120: 110438. PMID: 40049074, DOI: 10.1016/j.clinimag.2025.110438.Peer-Reviewed Original ResearchConceptsOverall survival of patientsBCLC staging systemTransarterial chemoembolizationOverall survivalStaging systemHepatocellular carcinomaStaging systems of hepatocellular carcinomaHepatocellular carcinoma staging systemsRetrospective single center studyKaplan Meier survival analysisInternational Staging SystemSingle center studyLog-rank testTertiary care centerPredicting overall survivalMeier survival analysisConsecutive patientsPrognostic stratificationStudy endpointPrognostic accuracyCenter studyPrognostic powerStratify outcomesMultivariate analysisPatients
2023
Use of overnight metyrapone test in suspected secondary adrenal insufficiency: A retrospective single centre‐study
Saini J, Garcia R, Herndon J, Erickson D, Gruber L, Bancos I. Use of overnight metyrapone test in suspected secondary adrenal insufficiency: A retrospective single centre‐study. Clinical Endocrinology 2023, 100: 203-211. PMID: 37997487, PMCID: PMC10872941, DOI: 10.1111/cen.14989.Peer-Reviewed Original ResearchConceptsDiagnosis of secondary adrenal insufficiencyOvernight metyrapone testSecondary adrenal insufficiencyCosyntropin stimulation testAdverse eventsAdrenal insufficiencyMetyrapone testPretest probabilityRetrospective study of adult patientsSingle-centre retrospective studyRetrospective single center studyDevelopment of adverse eventsStudy of adult patientsSingle center studyModerate pretest probabilityAdult patientsStimulation testCenter studyPatientsInsufficiencyDiagnosisCosyntropinSAT300 Use of Overnight Metyrapone Test In Suspected Adrenal Insufficiency: A Retrospective Single Center-Study
Saini J, Garcia R, Herndon J, Erickson D, Gruber L, Bancos I. SAT300 Use of Overnight Metyrapone Test In Suspected Adrenal Insufficiency: A Retrospective Single Center-Study. Journal Of The Endocrine Society 2023, 7: bvad114.304. PMCID: PMC10554100, DOI: 10.1210/jendso/bvad114.304.Peer-Reviewed Original ResearchDiagnosis of secondary adrenal insufficiencyOvernight metyrapone testSecondary adrenal insufficiencyCosyntropin stimulation testPre-test probabilityAdrenal insufficiencyMetyrapone testSingle center retrospective studyRetrospective single center studyExogenous glucocorticoid useSuspected adrenal insufficiencyChronic opioid useSingle center studyEvaluation of symptomsOvernight metyraponeMedian doseGlucocorticoid useOpioid useRetrospective studyStimulation testAdverse eventsCenter studyCortisol suppressionPatientsRisk factors
2010
Stent com liberação de everolimus vs. stent com liberação de zotarolimus na prática clínica do mundo real
Collet C, Costa J, Feres F, Gama G, Costa R, Sanchez A, Siqueira D, Chamié D, Borghi T, Staico R, Tanajura L, Sousa A, Abizaid A, Sousa J. Stent com liberação de everolimus vs. stent com liberação de zotarolimus na prática clínica do mundo real. Journal Of Transcatheter Interventions 2010, 18: 400-406. DOI: 10.1590/s2179-83972010000400008.Peer-Reviewed Original ResearchMonths of follow-upAdverse cardiac eventsDrug-eluting stentsCardiac eventsFollow-upRate of target-lesion revascularizationTarget-lesion revascularization rateStent thrombosisSingle center studyNon-selected patientsExcellent safety profileDrug-eluting stent generationTarget-lesion revascularizationPercutaneous coronary interventionAngiographic scenariosSafety profileCenter studyRevascularization ratesDiabetes mellitusCoronary interventionPatientsStentReference diameterEE groupLesion length
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply